Medovex Corp. Common Stock
MDVX
MDVX was delisted on the 15th of November, 2017.
6 hedge funds and large institutions have $86K invested in Medovex Corp. Common Stock in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
51% more capital invested
Capital invested by funds: $57K → $86K (+$29K)
0% more funds holding
Funds holding: 6 → 6 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$63.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.92K |
| 3 |
Citigroup
New York
|
+$410 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2.94K |
MDVX Hedge Fund Activity: Q3 2015 in Review
6 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Medovex Corp. Common Stock (MDVX) for Q3 2015, worth a combined $86K — up 51% from $57K a quarter earlier.
Fund positioning in MDVX was balanced in Q3 2015: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $63.6K. The largest seller was Tower Research Capital (TRC), cutting an estimated $2.94K.
- 6 institutional investors held Medovex Corp. Common Stock (MDVX) as of Q3 2015, unchanged from Q2 2015.
- Funds reported $86K of Medovex Corp. Common Stock stock for Q3 2015, up 51% quarter-over-quarter.
- 1 fund opened new Medovex Corp. Common Stock positions in Q3 2015 and 1 closed out, a net change of 0 holders.
- The largest Medovex Corp. Common Stock buyer in Q3 2015 was Millennium Management, an estimated $63.6K added.
- The largest Medovex Corp. Common Stock seller in Q3 2015 was Tower Research Capital (TRC), an estimated $2.94K sold.
Based on aggregated 13F filings for Q3 2015.